Congratulations on the successful holding of the 28th Lingnan Forum on Clinical Trials (the Advanced Class on Early Clinical Trials of Innovative Drugs)
Congratulations on the successful holding of the 28th Lingnan Forum on Clinical Trials (the Advanced Class on Early Clinical Trials of Innovative Drugs)
1. Advanced class of early clinical trial technology for innovative drugs was held smoothly.
In recent years, with the strong support of the policy, China is developing from a big country of generic drugs to a powerful country of innovative drugs, which is both an unprecedented good opportunity and a huge challenge for all parties involved in innovative drug research and development. In order to enhance the communication between relevant parties and further familiarize themselves with the new progress and requirements in the field of early clinical trials for innovative drugs, the "Advanced Class for Early Clinical Trials for Innovative drugs" was held online on March 20, 2022.
.jpg)
2.Mrs. Huang Haiyan shared her thoughts.
This training course is held by Guangdong Pharmacological Society and Clinical Pharmacology Committee of Guangdong Pharmacological Society, co-organized by Clinical Trials Evalutation Committee of Guangdong Food&Drug Technology Association for Evaluation and Certification, the Stage I & BE (Consistency Evaluation) Clinical Tesearch Combined Platform of Guangdong Hong Kong and Macau, Key Laboratory of Guangdong Innovative Drug Pharmacokinetics Research and Rvaluation, Institute of Clinical Pharmacology, Sun Yat-sen University, and undertook by Guangzhou Panyu Central Hospital .
2.Mrs. Huang Haiyan shared her thoughts.
This training class invited a number of domestic senior clinical trial experts and scholars to participate actively. Yang Hui, deputy director of Drug Clinical Trial Research Center of Guangzhou Panyu Central Hospital, presided over the training course. Wu Junyan (chief pharmacist of Sun Yat-sen Memorial Hospital, Sun Yat-sen University), Wen Yuguan (chief pharmacist of the Affiliated Brain Hospital of Guangzhou Medical University), Li Su(researcher of Sun Yat-sen University Cancer Center), Yuan Gang (associate chief physician of The First Affiliated Hospital, Sun Yat-sen University), Huang Haiyan (associate general manager of Beijing YEEDOZENCOM Healthcare Science and Technology Co., LTD.) Zhong Guoping (associate professor of Institute of Clinical Pharmacology, Sun Yat-sen University)， Li Guangze (associate general manager of Tianjin Clin-Nov Medical Co., LTD.), and Ding Changhai (professor of Zhujiang Hospital of Southern Medical University) gave lectures for this training class. Mrs. Huang Haiyan of yeedo shared the course "Learning experience and communication of clinical Pharmacology Research of Innovative Drugs and PK Research Guidelines for Patients with Renal insufficiency".
3. Conclusion
This course let the academic circle learn about the new progress and requirements in early clinical trial research of innovative drugs, and actively promoted the extensive communication of clinical trial research. The forum achieved a complete success.
Note: The news is excerpted from the official website of Guangdong Pharmacological Society.
.
